Abstract
Objectives:
To estimate the long-term clinical outcome of
patients with recurrent clear cell carcinoma (RCCC) of the ovary in
comparison with those with recurrent serous adenocarcinoma (RSAC).
Conclusions: The long-term clinical outcome of patients
with RCCC was extremely poor. We confirmed that RCCC (recurrent clear cell carcinoma) should be
investigated as a different malignancy compared with RSAC.
No comments:
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.